MDM2 and acute myeloid leukemia: In children with r/r AML, Aileron (ALRN)-6924 (a dual MDM2/MDMX inhibitor) in combination with Cytarabine is now being investigated for the first time through an ongoing Phase 1 trial (NCT03654716).